135 related articles for article (PubMed ID: 30087108)
21. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.
Goldman JM; Majhail NS; Klein JP; Wang Z; Sobocinski KA; Arora M; Horowitz MM; Rizzo JD
J Clin Oncol; 2010 Apr; 28(11):1888-95. PubMed ID: 20212247
[TBL] [Abstract][Full Text] [Related]
22. Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data.
Poch Martell M; Hamad N; Shin E; Moon JH; Sohn SK; Uhm J; Michelis FV; Viswabandya A; Lipton JH; Messner HA; Kim DDH
Eur J Haematol; 2017 Aug; 99(2):160-168. PubMed ID: 28449187
[TBL] [Abstract][Full Text] [Related]
23. Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2.
Michelis FV; Messner HA; Atenafu EG; McGillis L; Lambie A; Uhm J; Alam N; Seftel MD; Gupta V; Kuruvilla J; Lipton JH; Kim DD
Bone Marrow Transplant; 2015 Nov; 50(11):1405-10. PubMed ID: 26168067
[TBL] [Abstract][Full Text] [Related]
24. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
[TBL] [Abstract][Full Text] [Related]
25. Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.
Nakaya A; Mori T; Tanaka M; Tomita N; Nakaseko C; Yano S; Fujisawa S; Sakamaki H; Aotsuka N; Yokota A; Kanda Y; Sakura T; Nanya Y; Saitoh T; Kanamori H; Takahashi S; Okamoto S
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1553-9. PubMed ID: 25034961
[TBL] [Abstract][Full Text] [Related]
26. Secondary solid cancer screening following hematopoietic cell transplantation.
Inamoto Y; Shah NN; Savani BN; Shaw BE; Abraham AA; Ahmed IA; Akpek G; Atsuta Y; Baker KS; Basak GW; Bitan M; DeFilipp Z; Gregory TK; Greinix HT; Hamadani M; Hamilton BK; Hayashi RJ; Jacobsohn DA; Kamble RT; Kasow KA; Khera N; Lazarus HM; Malone AK; Lupo-Stanghellini MT; Margossian SP; Muffly LS; Norkin M; Ramanathan M; Salooja N; Schoemans H; Wingard JR; Wirk B; Wood WA; Yong A; Duncan CN; Flowers ME; Majhail NS
Bone Marrow Transplant; 2015 Aug; 50(8):1013-23. PubMed ID: 25822223
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Beelen D; Ciceri F; Volin L; Shimoni A; Foá R; Milpied N; Peccatori J; Polge E; Mailhol A; Mohty M; Savani BN
Cancer; 2017 Jul; 123(14):2671-2679. PubMed ID: 28329410
[TBL] [Abstract][Full Text] [Related]
28. Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada.
Acuna SA; Fernandes KA; Daly C; Hicks LK; Sutradhar R; Kim SJ; Baxter NN
JAMA Oncol; 2016 Apr; 2(4):463-9. PubMed ID: 26746479
[TBL] [Abstract][Full Text] [Related]
29. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
30. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
[TBL] [Abstract][Full Text] [Related]
31. Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major.
Santarone S; Pepe A; Meloni A; Natale A; Pistoia L; Olioso P; Papalinetti G; Cuccia L; Spasiano A; Lisi R; Di Ianni M; Bonfini T; Accorsi P; Salvadori S; Papola F; Angelini S; Di Bartolomeo P
Bone Marrow Transplant; 2018 Jan; 53(1):39-43. PubMed ID: 28991245
[TBL] [Abstract][Full Text] [Related]
32. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
33. Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.
van Gelder M; de Wreede LC; Bornhäuser M; Niederwieser D; Karas M; Anderson NS; Gramatzki M; Dreger P; Michallet M; Petersen E; Bunjes D; Potter M; Beelen D; Cornelissen JJ; Yakoub-Agha I; Russell NH; Finke J; Schoemans H; Vitek A; Urbano-Ispízua Á; Blaise D; Volin L; Chevallier P; Caballero D; Putter H; van Biezen A; Henseler A; Schönland S; Kröger N; Schetelig J
Bone Marrow Transplant; 2017 Mar; 52(3):372-380. PubMed ID: 27941763
[TBL] [Abstract][Full Text] [Related]
34. Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan.
Imamura M; Asano S; Harada M; Ikeda Y; Kato K; Kato S; Kawa K; Kojima S; Morishima Y; Morishita Y; Nakahata T; Okamura J; Okamoto S; Shiobara S; Tanimoto M; Tsuchida M; Atsuta Y; Yamamoto K; Tanaka J; Hamajima N; Kodera Y
Int J Hematol; 2006 Feb; 83(2):164-78. PubMed ID: 16513537
[TBL] [Abstract][Full Text] [Related]
35. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
36. Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period.
Chen CY; Lai CH; Lee KD; Huang SH; Dai YM; Chen MC
Gynecol Oncol; 2012 Dec; 127(3):625-30. PubMed ID: 22975362
[TBL] [Abstract][Full Text] [Related]
37. Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia.
Yamasaki S; Hirakawa A; Aoki J; Uchida N; Fukuda T; Ogawa H; Ohashi K; Kondo T; Eto T; Kanamori H; Okumura H; Iwato K; Ichinohe T; Kanda J; Onizuka M; Kuwatsuka Y; Yanada M; Atsuta Y; Takami A; Yano S
Ann Hematol; 2017 Feb; 96(2):289-297. PubMed ID: 27838773
[TBL] [Abstract][Full Text] [Related]
38. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.
Pavlů J; Labopin M; Zoellner AK; Sakellari I; Stelljes M; Finke J; Fanin R; Stuhler G; Afanasyev BV; Bloor AJ; Anagnostopoulos A; Mohty M; Giebel S; Nagler A
Cancer; 2017 Jun; 123(11):1965-1970. PubMed ID: 28211939
[TBL] [Abstract][Full Text] [Related]
40. Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia.
Aldoss I; Al Malki MM; Stiller T; Cao T; Sanchez JF; Palmer J; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2016 Mar; 22(3):575-8. PubMed ID: 26493564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
